How should a 3‑year‑old child with four days of fever, red lips, strawberry tongue, cough and no rash on exam be evaluated and treated for possible incomplete Kawasaki disease?

Immediate Evaluation and Treatment for Incomplete Kawasaki Disease

This 3-year-old child with 4 days of fever, red lips, strawberry tongue, and cough—even without visible rash on exam—should be urgently evaluated for incomplete Kawasaki disease (IKD) with laboratory tests (ESR, CRP, CBC, albumin, ALT) and echocardiography, and if criteria are met, treated immediately with IVIG 2 g/kg plus aspirin to prevent coronary artery aneurysms.

Why This Child Warrants Urgent Evaluation

This presentation is concerning for incomplete KD because:

• Fever ≥4 days with only 2-3 classic criteria (red lips, strawberry tongue, possible rash per mother's history)
• Age 3 years falls within the highest-risk group (under 5 years) 1
• Cough as presenting symptom is increasingly recognized in IKD cases and should not distract from the diagnosis 2

The absence of rash on your examination does not exclude KD—the mother observed it, and KD rashes are often transient and polymorphous 1.

Algorithmic Approach to Diagnosis

Step 1: Apply the AHA Incomplete KD Algorithm

Since this child has fever ≥4 days with only 2-3 classic criteria, follow the incomplete KD evaluation pathway 1:

Obtain immediately:

• ESR and CRP
• Complete blood count with differential
• Serum albumin
• ALT (alanine aminotransferase)
• Urinalysis

Critical laboratory thresholds supporting IKD 1:

• CRP ≥3.0 mg/dL and/or ESR elevated
• Albumin <3.0 g/dL
• Anemia for age
• Platelet count ≥450,000/mm³ after day 7
• WBC ≥15,000/mm³
• Urine ≥10 WBC/high-power field

Step 2: Obtain Echocardiography

Perform transthoracic echocardiography urgently to assess for coronary artery abnormalities (Z-score >2.5 indicates dilation) 1. This is both diagnostic and prognostic.

Step 3: Treatment Decision

Treat with IVIG if ANY of the following 1:

• ≥3 supplemental laboratory criteria are positive
• Coronary artery Z-score >2.5 on echo
• CRP >3.0 mg/dL with persistent fever and clinical concern

Treatment Protocol

Standard therapy consists of 1:

1. IVIG 2 g/kg as single infusion over 10-12 hours
2. Aspirin (dosing per institutional protocol, typically high-dose 80-100 mg/kg/day during acute phase)

Timing is critical: Initiate treatment as soon as diagnosis is established, ideally within the first 10 days of fever onset 1. Even though this child is on day 4, do not delay—earlier treatment reduces coronary artery aneurysm risk from ~25% to <5% 3.

Key Clinical Pitfalls to Avoid

Pitfall 1: Dismissing the Diagnosis Due to Cough

Recent case reports demonstrate that severe cough can be the predominant initial symptom of IKD 2. A 3-year-old boy presented with cough followed by fever, conjunctival hemorrhage, elevated ESR/CRP, and poor response to antibiotics—ultimately diagnosed with IKD and successfully treated with IVIG 2. The cough resolved within 2 days of IVIG treatment 2.

Pitfall 2: Waiting for More Classic Features

Do not wait for additional criteria to develop 4. Incomplete KD accounts for a significant proportion of cases, particularly in young children, and delayed recognition leads to higher rates of coronary complications 4, 5.

Pitfall 3: Assuming Antibiotics Should Work First

If this child has elevated inflammatory markers (ESR/CRP) and poor response to antibiotics, this pattern strongly suggests KD rather than bacterial infection 2.

Post-Treatment Monitoring

After IVIG administration:

• Monitor for defervescence (should occur within 24-48 hours)
• Repeat echocardiography at 2 weeks and 6-8 weeks post-diagnosis 1
• If fever persists >36 hours after IVIG completion, consider IVIG-resistant KD requiring second-line therapy 1

Evidence Strength and Nuances

The 2017 AHA Scientific Statement 1 provides the most authoritative guideline framework, emphasizing that the incomplete KD algorithm exists precisely because "the low risks associated with IVIG administration and the high risks of coronary artery aneurysms among children who do not receive timely treatment" justify aggressive evaluation and treatment 1.

European consensus recommendations 5 align with AHA guidelines, reinforcing the importance of early treatment in both complete and incomplete KD. The evidence consistently shows that treatment benefit outweighs risk when clinical suspicion is appropriate 1, 5, 3.